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Summary.-B lymphocytes from the peripheral blood of 15 melanoma patients and
14 normal adults were studied using immunofluorescence to IgA, IgG, IgD and IgM
surface markers. The total number ofperipheral blood B lymphocytes was increased
in the melanoma patients (1048/mm3) compared with normal controls (504) (P<0*01).
The expression of excess IgD bearing lymphocytes in these melanoma patients
may reflect a derepression of oncofoetal type.
HIGH LEVELS of IgD bearing lympho-
cytes are found in the foetus, newborn
and children, but these fall to low levels in
the peripheral blood ofadults (Rowe et al.,
1973).
In a routine examination of B lympho-
cyte function in various malignancies, we
discovered that a high number of the
peripheral lymphocytes in melanoma
patients had IgD on their surface. To
our knowledge this finding has not been
reported previously.
MATERIALS AND METHODS
Patients. Fifteen patients with histo-
logically proven malignant melanoma from
Stage I to Stage III were studied; 14 normal
healthy adult laboratory staff (age 20-40
years) were used as controls.
Samples.-10-20 ml heparinized blood.
Lymphocytes were separated using Lympho-
prep (Nyegaard & Co., Oslo). Lymphocyte
morphology, staining with specific antisera,
examination for fluorescent labelling and
specificity controls were carried out using
the method of McLaughlin et al. (1973).
Total and differential white cell counts
w-ere done in each case.
Antisera.-Commercially obtained fluores-
cein conjugated monospecific antisera to
human IgG, IgA, IgM, and IgD were used
(Behringwerke AG, Batch Nos: 572A, F504Q,
580B and F492P respectively).
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RESULTS
Morphology
More than 9000 of cells obtained were
lymphocytes. The remaining cells were
polymorphs and monocytes.
Staining
The varieties of staining (cells heavily
stained with large dots, others with
numerous smaller dots, and others with
ring or cap formation) as described pre-
viously, were observed throughout in both
the normnal controls and the melanoma
patients. There was no evidence to
suggest any maturation error or synchro-
nization. Trypsinization and washing in
a few studies resulted in regeneration of
the same proportions of cells.
Melanoma patients
The total numbers of Ig-bearing
lymphocytes in the peripheral blood were
increased (P < 0.01) and there was a
corresponding diminution in the number
of non-Ig-bearing cells (P < 0 001), see
Table which shows that this is due to an
increase in the total number of lympho-
cytes bearing IgG (P < 0.02) or IgD,
especially the latter, which were some 5
times more numerous than in controlsS. MALKA, C. J. OON AND J. R. HOBBS
TABLE.-The Percentage and Absolute Number ofIg-Bearing Lymphocytes in 14 Normal
Individuals and 15 MelanomaPatients
Cells/mm3
Total Ig-bearing
Total non-Ig-bei
Group
IgG Normal
Melanoma
IgD Normal
Melanoma
IgA Normal
Melanoma
IgM Normal
Melanoma
Y, Normal
Melanoma
aring Normal
Melanoma
* N.S. = not significant.
IgG (NORMAL)
Lymphocytes (%)
8-16
9-35
0- 8
1-48
2-12
0-20
4-13
0-17
15-41
21-96
59-85
2-79
Observed
range
101- 354
166- 857
0- 266
16-1385
14- 440
0- 746
58- 442
0- 393
252-1505
426-3402
723-2922
47-1604
Log-normal calculated
Mean ±2 s.d. t13 P
195 103- 369 2-76 <0-02
322 92-1122
80 0- 397 3-00 <0-01
422 18-1231
94 15- 590 0-43 N.S.*
114 6-2089
109 40- 301 0-28 N.S.*
98 5-1791
504 205-1242 3-26 <0-01
1048 241-4560
1343 676-2667 4-61 <0-001
352 42-2974
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CELLS/mnm3 CELLS/mm13
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FIG.-Frequency distributions observed in normal controls (top) and melanoma patients (bottom)
for IgG- and IgD bearing lymphocytes.
(P < 0-01). There was no significant
difference for IgA or IgM bearing cells.
The study was too small to differen-
tiate the differences between those in
" remission " and those with active dis-
ease clinically, though the patients with
clinically apparent disease had consistently
high peripheral IgD lymphocyte counts of
greater than 270/mm3 (above the range of
0-266/mm3 in normal adults).
The Figure shows the frequency distri-
bution observed in normal controls and
melanoma patients for IgG and IgD
bearing lymphocytes. In melanoma
patients these are increased for IgG and
IgD.
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DISCUSSION
High levels of IgD bearing lympho-
cytes are reported in newborns, but
hitherto there have been no published
reports of their presence in malignant
diseases in man.
In separate studies Rowe et al. (1973)
have used percentages in expressing their
results and have shown that mean levels
of IgD bearing lymphocytes were 14.5%
in cord blood of newborn and 3.8% in
adults. However, percentages are not
satisfactory expressions of the quantity
of lymphocytes that were studied.
Using numbers/mm3 the log-normal
distributions of both Ig-bearing and non-
Ig-bearing lymphocytes become obvious
(see Figure, McLaughlin et al. (1973))
and correct log-normal statistics can be
applied to assess significance.
The decrease in non-Ig-bearing lym-
phocytes, especially in patients in relapse,
is in agreement with the absence of the
mixed lymphocyte reaction found in half
of the patients with Stage II (and worse)
melanomatosis (Butterworth et al., 1974).
It also accords with a significant
reduction in melanoma patients of
peripheral lymphocytes (presumably " T ")
forming spontaneous rosettes with sheep
erythrocytes (Bourgoinetal., unpublished).
The finding of increased Ig-bearing
lymphocytes, mainly IgD-bearing cells,
may have two causes. With a fall of T
lymphocyte function, more B lymphocytes
might emerge and in such a situation of
regeneration there might be an excess
of IgD-bearing cells. We are exploring
this in similar conditions. Alternatively,
there may be a true foetal throwback.
Recently, Carrel and Theilkaes (1973)
have found an antigen in melanoma
patients, and the antisera to this antigen
also cross react with antigens in patients
with neuroblastoma and ganglioneuroma.
Since the precursor cells, common to all
three tumours, are thought to originate
in the embryonic neural tube, it is possible
that this common antigen may be of
oncofoetal origiti. Our finding of an
increase in IgD-bearing lymphocytes in
our melanoma patients could therefore
support a hypothesis of a possible onco-
foetal throwback in melanomatosis. This
may be derepression of an oncofoetal
type.
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